Marlena Osowski
Registered Nurse · Framingham, MANPI 1386335776
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 28.7% of the total.
Across 20 payments — averaging $25.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$145
- Bristol Myers Squibb$84
- Gilead$55
- Sanofi$39
- Regeneron Healthcare Solutions, Inc.$37
- Lilly USA, LLC$37
- plus $108 from 5 others
What the payments were for
- Food & beverage$505100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $145 |
| Bristol Myers Squibb | 4 | $84 |
| Gilead | 2 | $55 |
| Sanofi | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Lilly USA, LLC | 2 | $37 |
| Pfizer | 1 | $26 |
| AbbVie | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $18 |
| Lucid Diagnostics Inc. | 1 | $18 |
How this compares
$505 in reported general payments places this provider in the 80th percentile of 124 registered nurse providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 21 | $425 |
| Pantoprazole Sodium | 22 | $361 |
| Famotidine | 15 | $222 |
Paid to pharmacies, not to this prescriber.
Other registered nurse in Framingham
- Marisa RotunnoFramingham$219
- Natalie ConstantineFramingham$98
- Alyssa D'arcyHanover$57K
- Maryann WeitzBoston$5K
- Nataliya SevastyanovaSpringfield$3K
- Shannon ListHyannis$3K
- Kendra PavaoFall River$2K
- Lindsay JonesNorth Andover$2K
- Hayley KochWorcester$2K
- Hannah PotlerWaltham$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.